Download Citation
Article Source:
Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma
Tahiri A,
Røe K,
Ree AH,
de Wijn R,
Risberg K,
et al.
(2013)
Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma.
PLOS ONE 8(8): e72692.
https://doi.org/10.1371/journal.pone.0072692